Contributing Member of the Healthcare Councils

Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.

GLG News by this Author

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

Pharma emphasis on emerging markets justified but more needs to be done to operate successfully

May 14, 2009

Analysis of:GSK expands into emerging markets with Aspen deal | www.telegraph.co.uk

Over the last five years many large pharma companies have expanded rapidly in emerging markets. Leading among the pack are Glaxo, Pfizer, Novartis, AstraZeneca and Bayer.Others are not far behind. MNCs have been smart in integrating emerging markets into their core operations. What needs furthet attention is a keener understanding on the part of MNCs re the operating environment in emrging markets and management cadre of more people with deep experience of operating in EMs.

Tactic to increase speed of offers to India Pharma companies

May 5, 2009

Analysis of:Indian drugmakers facing takeover threat: Govt panel | www.business-standard.com

Reading between the lines .. this appears to be a tactic to get more deals done quickly by scaring buyers of government intervention. Indian generic pharmas have gotten undreamt of valuations.Others are drooling over these.

Page : 11 to 2 of 2

Subscribe to Updates

By RSS